Loading data for DOCS — first visit, this takes a few seconds.

Doximity, Inc. (DOCS)

NYSE: DOCS · 即時價格 · USD

26.71

-0.02 (-0.07%)

收盤價： Aug 31, 2026, 3:59 PM

26.55

-0.60%

盤前: 5:18 AM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

-0.07% (1D)

買價	0
市值	4.76B
營收 (ttm)	656M
淨利（ttm）	167M
	1.21
	0.84
	31.8
	17.24
P/B (ttm)	5.24
P/S (ttm)	7.26
財報日期	Nov 5, 2026

賣價	0
成交量	2,194,184
20 日平均成交量	4,745,867
開盤價	25.84
前收盤價	26.73
當日區間	25.84 - 26.85
52 週範圍	17.15 - 76.51
分析師	n/a
目標價	n/a
股利	n/a
除息日	n/a

關於 DOCS

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored ...

[閱讀更多]

產業 Health Information Services

類股 Healthcare

IPO 日期 Jun 24, 2021

員工 880

證券交易所 NYSE

股票代號 DOCS

網站 https://www.doximity.com

完整的公司簡介

財務表現

Doximity 在 2026 年的營收為 644.86M，較前一年的 570.4M 增加 13.05%。淨利為 196.05M，較前期減少 -12.16%。

財務報表

財報驚奇

Doximity 已於 Aug 6, 2026 公布季度財報：

營收為 $156.62M 低於預期 $0, 年增 7.34% 成長.
每股盈餘為 0.29 低於預期 -0.01, 年增 -19.44% 下滑.

下次財報發布

Doximity, Inc. 的下次財報預計於 Nov 5, 2026, 盤中。
分析師預估營收 ... 升級

價格為何變動

新聞動態

3 天前 · StockStory

Amplitude, GitLab, Doximity, Freshworks, and Sprinklr Shares Skyrocket, What You Need To Know

A number of stocks jumped in the afternoon session after quarterly earnings and upbeat corporate commentary signaled that artificial intelligence is driving growth across enterprise software rather th...

4 天前 · StockStory

1 Software Stock on Our Buy List and 2 Facing Challenges

Software is eating the world, and virtually no business is left untouched by it. Companies bringing it to life have been rewarded with explosive earnings growth, and the upward trend shows no signs of...

1 週前 · Zacks

Reasons to Retain Doximity Stock in Your Portfolio for Now

DOCS' AI expansion is opening new growth avenues, but rising AI costs and tight pharma budgets could temper near-term gains.

1 週前 · Zacks

HIMS Stock More Than Doubled in 6 Months: What's Driving the Rally?

Hims & Hers' rally is fueled by branded weight-loss growth, international expansion, AI efficiencies and a broader specialty portfolio.

1 週前 · Simply Wall St.

Doximity (DOCS) Stock Looks Cheap On Cash Flow Yet Fair On Earnings

Doximity stock has had a difficult five year stretch, with shareholders seeing the share price decline 71.8%, even as recent AI driven products have drawn fresh attention. At the current price near US...

第 1 頁，共 2 頁

Doximity, Inc. (DOCS)